摘要
透明质酸填充剂注射可有效改善面部凹陷、皮肤静态皱纹和组织轮廓,同时因其安全可吸收、操作便利,且效果立即显现,成为目前微创注射美容项目中最常使用的填充剂。贝丽姿-注射用交联透明质酸钠凝胶上市不久即得到众多专家及就医者的认可,为了使治疗更加有效和安全,同时尽可能降低治疗过程中不良反应的发生率,于2018年7月制定并发布了《贝丽姿-注射用交联透明质酸钠凝胶专家共识(2018)》。本共识内容涉及贝丽姿-注射用交联透明质酸钠凝胶的产品特点、有效性和安全性、适应证、禁忌证、术中操作、注意事项、并发症及处理等多个方面,为使用贝丽姿的专业医师提供了规范化的操作建议和参考资料。
Hyaluronic acid filler injection can effectively improve facial depression, skin static wrinkles and tissue contour, and it is safe to absorb, easy to operate, and the effect is immediately apparent. It has become one of the most popular filler used in minimally invasive injection beauty projects. Cross-linked Sodium Hyaluronic Acid Gel(Beilizi) has been soon approved by many experts and beauty seekers.In order to make treatment more effective and safe, and to minimize the incidence of adverse reactions during treatment,"Chinese expert consensus document on Cross-linked Sodium Hyaluronic Acid Gel(Beilizi)2018"was developed and released in July 2018. This Consensus covers the product characteristics, effectiveness,and safety of Cross-linked Sodium Hyaluronic Acid Gel(Beilizi), indications, contraindications, procedures, precautions,complications, and handling. In many ways, standardized practice recommendations and references are provided for professional physicians.
出处
《中国美容医学》
CAS
2019年第6期73-77,共5页
Chinese Journal of Aesthetic Medicine
关键词
微创注射
填充剂
专家共识
贝丽姿-注射用交联透明质酸钠凝胶
minimally invasive injection
filler
expert consensus
Cross-linked Sodium Hyaluronic Acid Gel(Beilizi)